ARS Pharmaceuticals (SPRY) Earnings Date, Estimates & Call Transcripts

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free SPRY Stock Alerts

$8.44

-0.62 (-6.84%)

(As of 04/18/2024 ET)

Compare

Upcoming Earnings Date: May. 20Estimated
Actual EPS (Mar. 21): -$0.07 Beat By $0.07
Consensus EPS (Mar. 21): -$0.14

Earnings Per Share Revenue

SPRY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SPRY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

ARS Pharmaceuticals Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2024	2	($0.18)	($0.14)	($0.16)
Q2 2024	2	($0.18)	($0.17)	($0.18)
Q3 2024	2	($0.18)	($0.16)	($0.17)
Q4 2024	2	($0.36)	($0.18)	($0.27)
FY 2024	8	($0.90)	($0.65)	($0.78)
Q1 2025	1	($0.19)	($0.19)	($0.19)
Q2 2025	1	($0.14)	($0.14)	($0.14)
Q3 2025	1	($0.04)	($0.04)	($0.04)
Q4 2025	1	($0.08)	($0.08)	($0.08)
FY 2025	4	($0.45)	($0.45)	($0.45)

SPRY Earnings Date and Information

ARS Pharmaceuticals last issued its quarterly earnings data on March 21st, 2024. The reported ($0.07) EPS for the quarter, beating analysts' consensus estimates of ($0.14) by $0.07. ARS Pharmaceuticals has generated ($0.57) earnings per share over the last year (($0.57) diluted earnings per share). Earnings for ARS Pharmaceuticals are expected to grow in the coming year, from ($0.69) to ($0.34) per share. ARS Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off prior year's report dates.

ARS Pharmaceuticals Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
5/20/2024 Estimated)	-	-	-	-	-	-	-
3/21/2024	Q4 2023	($0.14)	($0.07)	+$0.07	($0.07)	-	-
11/9/2023	Q3 2023	($0.18)	($0.16)	+$0.02	($0.16)	-	-
8/10/2023	Q2 2023	($0.17)	($0.18)	($0.01)	($0.18)	-	$0.01 million
5/15/2023	Q1 2023	($0.17)	($0.16)	+$0.01	($0.16)	-	$0.02 million
11/2/2022	Q3 2022	-	($0.50)	($0.50)	($0.50)	-	-
8/11/2022	Q2 2022	($0.62)	($0.55)	+$0.07	($0.55)	-	-
Get the Latest News and Ratings for SPRY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for ARS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
5/12/2022	Q1 2022	($0.67)	($0.70)	($0.03)	($0.70)	-	-
3/31/2022	Q4 2021	($0.70)	($0.67)	+$0.03	($0.67)	-	-
11/10/2021	Q3 2021	($0.72)	($0.65)	+$0.07	($0.65)	-	-
8/12/2021	Q2 2021	($0.57)	($0.70)	($0.13)	($0.70)	-	-
5/13/2021	Q1 2021	($0.37)	($0.54)	($0.17)	($0.54)	-	-

ARS Pharmaceuticals Earnings - Frequently Asked Questions

When is ARS Pharmaceuticals's earnings date?: ARS Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off last year's report dates. Learn more on SPRY's earnings history.
Did ARS Pharmaceuticals beat their earnings estimates last quarter?: In the previous quarter, ARS Pharmaceuticals (NASDAQ:SPRY) reported ($0.07) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.14) by $0.07. Learn more on analysts' earnings estimate vs. SPRY's actual earnings.

How much revenue does ARS Pharmaceuticals generate each year?: ARS Pharmaceuticals (NASDAQ:SPRY) has a recorded annual revenue of $30,000.00.
How much profit does ARS Pharmaceuticals generate each year?: ARS Pharmaceuticals (NASDAQ:SPRY) has a recorded net income of -$54.37 million. SPRY has generated -$0.57 earnings per share over the last four quarters.
What is ARS Pharmaceuticals's EPS forecast for next year?: ARS Pharmaceuticals's earnings are expected to grow from ($0.69) per share to ($0.34) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:SPRY) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

ARS Pharmaceuticals (SPRY) Earnings Date, Estimates & Call Transcripts

SPRY Earnings Estimates and Actuals by Quarter

SPRY Estimated and Actual Revenue by Quarter

ARS Pharmaceuticals Analyst EPS Estimates

SPRY Earnings Date and Information

ARS Pharmaceuticals Earnings History by Quarter

ARS Pharmaceuticals Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ARS Pharmaceuticals (SPRY) Earnings Date, Estimates & Call Transcripts

Earnings Summary

SPRY Earnings Estimates and Actuals by Quarter

SPRY Estimated and Actual Revenue by Quarter

ARS Pharmaceuticals Analyst EPS Estimates

SPRY Earnings Date and Information

ARS Pharmaceuticals Earnings History by Quarter

ARS Pharmaceuticals Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat